Synergistic Mechanisms and Clinical Progress of Radionuclide Therapy Combined with Immune Checkpoint Inhibitors in Colorectal Cancer.

Fan Q, Fu Z, Xu M, Luo Z, Xiong D

Open source

DOI
10.1177/10849785261466877
Published
2026 Jul 21
Container
Cancer biotherapy & radiopharmaceuticals
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/10849785261466877,
  title = {Synergistic Mechanisms and Clinical Progress of Radionuclide Therapy Combined with Immune Checkpoint Inhibitors in Colorectal Cancer.},
  author = {Fan Q and Fu Z and Xu M and Luo Z and Xiong D},
  year = {2026},
  journal = {Cancer biotherapy \& radiopharmaceuticals},
  doi = {10.1177/10849785261466877},
  url = {https://doi.org/10.1177/10849785261466877}
}

RIS

TY  - JOUR
TI  - Synergistic Mechanisms and Clinical Progress of Radionuclide Therapy Combined with Immune Checkpoint Inhibitors in Colorectal Cancer.
AU  - Fan Q
AU  - Fu Z
AU  - Xu M
AU  - Luo Z
AU  - Xiong D
PY  - 2026
JO  - Cancer biotherapy & radiopharmaceuticals
DO  - 10.1177/10849785261466877
UR  - https://doi.org/10.1177/10849785261466877
ER  - 

APA

Q, F., Z, F., M, X., Z, L., & D, X. (2026). Synergistic Mechanisms and Clinical Progress of Radionuclide Therapy Combined with Immune Checkpoint Inhibitors in Colorectal Cancer.. Cancer biotherapy & radiopharmaceuticals. https://doi.org/10.1177/10849785261466877

Source records